Advertisement

Topics

Latest "LithoLink Corporation" News Stories - Page: 2

12:57 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "LithoLink Corporation" found in our extensive news archives from over 250 global news sources.

More Information about LithoLink Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about LithoLink Corporation for you to read. Along with our medical data and news we also list LithoLink Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of LithoLink Corporation Companies for you to search.

Showing "LithoLink Corporation" News Articles 26–50 of 523

Relevant

Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network

Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has engaged a nationwide network of professional sales representatives (“sales reps”) to sell and distribute t...


International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products

CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that its wholly owned subsidiary, Lifeline Cell Technology (LCT), has expanded its business and manufacturing capabilities to ful...

Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain

Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer.  Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will col...


Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing

Sunnyvale, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to rea...

Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists

Sunnyvale, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team aced three consecutive rounds of blinded-specimen Proficiency Testing (PT) with the College of American Pathologists (CAP).  The SC-2017, SA-2018 and SB-2018 triannual CAP Diagnostic Immunology Surveys require highly quantitative measu...

International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market

CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it raised $500,000 from a private investor not affiliated with the Company or its managemen...

Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events

Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMerge Abstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology Meeting (ASH) in December Conference call scheduled for 4:30 p.m. ET today MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced recent company events a...

International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research

CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it has been valued at $34 million, up from $33 million in January 2018, by Edison Investment Research ("Edison")*, a world-re...

Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics

Sunnyvale, July 30, 2018 (GLOBE NEWSWIRE) -- July 30, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, signs allergy testing contracts with a consortium of medical clinics nationwide.  The network comprises 178 medical clinics in 29 of the 48 contiguous United States including the Northeast, Southeast, Midwest, South, Southwest, Pacif...

Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events

MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, 2018. Second Quarter and Year to Date 2018 Results For the second quarter of 2018, the Company reported a net loss of $6.9 million, or $0.04 per share, compared to $6.4 million, or $0.04 per share, for the comparable 2017 period. ...

International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company a key patent ...

Probably Relevant

Global and Asia Instant Adhesive Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics

Sunnyvale, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, launches a fully automated allergy testing portal for doctors and clinics to streamline and accelerate the allergy testing and treatment process. The Patient Data Solutions (PDS) allergy-testing suite is secure and fully compliant with Health Insurance Portability an...

International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial

CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the second patient of the third cohort of the clinical trial for Parkinson's disease was successfu...

International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018

CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update announcing operating results for the three months ended March 31, 2018. “This...

International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial

CARLSBAD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the first patient of the third cohort of the clinical trial for Parkinson's disease was successful...

Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains

Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores.  The retailer collected finger stick blood specimens from 126 customers at their in-store clinics, and s...

Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration

Sunnyvale, July 16, 2018 (GLOBE NEWSWIRE) -- July 16, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the...

Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technologyCustomers to benefit from simplified, scalable solutions for intensified cell culture GÖTTINGEN, Germany and WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Sartorius Stedim Biotech (SSB) (Euronext: DIM), a leading international supplier...

Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration

Sunnyvale, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports the shipment of clinical instrumentation and quantification software to the United States Food and Drug Administration (FDA).  Arrayit uses the same instrumentation and software to test for allergy and food intolerance as well as pipeline indications for ov...

International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting

CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today it will present at the Society for Neuroscience Annual Meeting (Neuroscience 2018), being held Novembe...

Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä

ORION CORPORATION         MANAGERS' TRANSACTIONS 7 MAY 2018 at 15.50 EETS Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associa...

International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River

TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of $500,000 from its strategic partner Voltage River (www.voltageriver.com). The capital injection will be used primarily for expanding the production of the Company’s newest p...

International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial

CARLSBAD, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today positive 12-month results of the first cohort and six-month interim results of the second cohort of it...

International Endeavors Corporation, a Medical Marijuana IP Holdings Company today announces the introduction of OGGL, OFF-GRID GROW LAB

TEMECULA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC:IDVV) is pleased to announce that After the appointment of new board member Andrew Read earlier this year, IDVV has introduced the OFF-GRID Grow Lab (OGGL). These container sized facilities will be designed using the latest in growing equipment and powered by off grid clean energy ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks